We endeavour to resolve some of the confusion surrounding the (mis) use of the term ‘colloidal silver’, particularly in a pharmaceutical context. It is proposed that, wherever possible, the term ‘colloidal silver’ be replaced by a clearer descriptor indicating a silver formulation’s composition and function, particularly when used either to help treat infections and/or to stimulate healing (as in restorative medicine).
Document Details
| Title : | ‘Colloidal Silver’: Recommendations to Remove This Misleading Term for Describing Nanoparticulate Silver Antimicrobial Agents |
| Published : | 25 April 2017 |
| Status: | Published |
| Author: | Hans Laroo and Michael Whitehouse |
| Pages : | 4 |
| Language : | English |